secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aprea Therapeutics, Inc. (APRE)
CIK:        0001781983
Form:       8-K
Filed at:   2026-01-09T23:59:59+00:00
Accession:  0001104659-26-002490
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aprea Therapeutics updates corporate presentation (January 2026)
----------------------------------------------------------------

- Filed updated corporate presentation as Exhibit 99.1 on January 9, 2026.
- No specific financial or operational details disclosed in the filing itself.
- Presentation content not provided; unable to extract material updates.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1781983/000110465926002490/0001104659-26-002490-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1781983/000110465926002490/apre-20260109x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-002490

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer